NCT00138385View on ClinicalTrials.gov

Comparison of Inactivated and Live, Attenuated Influenza Vaccine in Children 5-9 Years of Age-Year 3 Amendment

PHASE4CompletedINTERVENTIONAL
Enrollment

40

Participants

Timeline

Start Date

August 31, 2005

Study Completion Date

June 30, 2007

Conditions
Influenza
Interventions
BIOLOGICAL

FluMist

BIOLOGICAL

Fluzone

Trial Locations (1)

94305

Stanford University, Stanford

All Listed Sponsors
lead

National Institute of Allergy and Infectious Diseases (NIAID)

NIH

NCT00138385 - Comparison of Inactivated and Live, Attenuated Influenza Vaccine in Children 5-9 Years of Age-Year 3 Amendment | Biotech Hunter | Biotech Hunter